Literature DB >> 6145520

The reversibility of "permanent" tardive dyskinesia.

H L Klawans, C M Tanner, A Barr.   

Abstract

Neuroleptic-induced tardive dyskinesia (TD) that persists for 1 year or more following withdrawal of neuroleptics is usually said to be permanent. Early spontaneous remissions have been well described but most such remissions occurred within the first few months following neuroleptic withdrawal, and no published studies have followed patients for more than 2 years to evaluate permanence of remission. Over the last 12 years, we studied six patients with TD who, on prolonged follow-up, were found to have complete remission of their abnormal movements after a neuroleptic-free period of more than 2 years (2 1/2-5 years). All six patients were 61 years old or younger when their TD was diagnosed and their neuroleptics withdrawn. In five of the patients, remission occurred while the patients were not taking medication for the movements, while one patient had been on long-term, high-dose (2 mg/day) reserpine therapy for more than 3 years. The incidence of late remission of TD is not known and cannot be estimated from these selected patients, but these cases demonstrate that persistence of abnormal movements of TD for 2 or more years following neuroleptic withdrawal does not imply permanence in all patients. We suggest that TD be considered a persistent rather than an invariably permanent disorder.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6145520     DOI: 10.1097/00002826-198406000-00006

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  6 in total

1.  Tardive dyskinesia: therapeutic options for an increasingly common disorder.

Authors:  Leslie J Cloud; Deepti Zutshi; Stewart A Factor
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 2.  Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia.

Authors:  J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Bilateral ballism induced by ibuprofen in a schizophrenic patient.

Authors:  R Sandyk; G Awerbuch; S Z Rapcsak
Journal:  Postgrad Med J       Date:  1987-07       Impact factor: 2.401

4.  Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose.

Authors:  M F Egan; T M Hyde; J E Kleinman; R J Wyatt
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

5.  Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: support for a model of tardive dyskinesia.

Authors:  J L Neisewander; E Castañeda; D A Davis
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530

Review 6.  Treatable Hyperkinetic Movement Disorders Not to Be Missed.

Authors:  Aurélie Méneret; Béatrice Garcin; Solène Frismand; Annie Lannuzel; Louise-Laure Mariani; Emmanuel Roze
Journal:  Front Neurol       Date:  2021-12-01       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.